Bristow MR - Search Results

1

Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.

Port JD, Debellis CC, Klein J, Peeters GA, Barry WH, Bristow MR. Port JD, et al. Among authors: bristow mr. J Pharmacol Exp Ther. 1992 Jul;262(1):217-24. J Pharmacol Exp Ther. 1992. PMID: 1352549

2

Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.

Anderson FL, Port JD, Reid BB, Hanson G, Kralios AC, Hershberger RE, Bristow MR. Anderson FL, et al. Among authors: bristow mr. J Cardiovasc Pharmacol. 1992;20(5):800-6. J Cardiovasc Pharmacol. 1992. PMID: 1280744

3

Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation.

Anderson FL, Port JD, Reid BB, Larrabee P, Hanson G, Bristow MR. Anderson FL, et al. Among authors: bristow mr. Circulation. 1992 Jan;85(1):46-53. doi: 10.1161/01.cir.85.1.46. Circulation. 1992. PMID: 1309447

4

Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.

Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV, et al. Bristow MR, et al. J Clin Invest. 1992 Mar;89(3):803-15. doi: 10.1172/JCI115659. J Clin Invest. 1992. PMID: 1311717 Free PMC article.

5

Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes.

Bristow MR, Larrabee P, Müller-Beckmann B, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD. Bristow MR, et al. Clin Investig. 1992;70 Suppl 1:S105-13. doi: 10.1007/BF00207620. Clin Investig. 1992. PMID: 1350478

6

Receptor pharmacology of carvedilol in the human heart.

Bristow MR, Larrabee P, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD, Müller-Beckmann B. Bristow MR, et al. J Cardiovasc Pharmacol. 1992;19 Suppl 1:S68-80. doi: 10.1097/00005344-199219001-00014. J Cardiovasc Pharmacol. 1992. PMID: 1378154

7

Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.

Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J, et al. Bristow MR, et al. Circulation. 1991 Sep;84(3):1024-39. doi: 10.1161/01.cir.84.3.1024. Circulation. 1991. PMID: 1653120

8

Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.

Gilbert EM, O'Connell JB, Bristow MR. Gilbert EM, et al. Among authors: bristow mr. Heart Vessels Suppl. 1991;6:29-39. doi: 10.1007/BF01752533. Heart Vessels Suppl. 1991. PMID: 1687924 Review.

9

Mechanism of action of bucindolol in human ventricular myocardium.

Hershberger RE, Wynn JR, Sundberg L, Bristow MR. Hershberger RE, et al. Among authors: bristow mr. J Cardiovasc Pharmacol. 1990 Jun;15(6):959-67. doi: 10.1097/00005344-199006000-00014. J Cardiovasc Pharmacol. 1990. PMID: 1694919

10

Mr 40,000 and Mr 39,000 pertussis toxin substrates are increased in surgically denervated dog ventricular myocardium.

Hershberger RE, Feldman AM, Anderson FL, Kimball JA, Wynn JR, Bristow MR. Hershberger RE, et al. Among authors: bristow mr. J Cardiovasc Pharmacol. 1991 Apr;17(4):568-75. doi: 10.1097/00005344-199104000-00007. J Cardiovasc Pharmacol. 1991. PMID: 1711622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters